Pinto Susanne, Benincà Elisa, Nooij Sam, Terveer Elisabeth M, Keller Josbert J, van der Meulen-de Jong Andrea E, Steyerberg Ewout W, Bogaards Johannes A
Department of Biomedical Data Sciences, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, the Netherlands.
Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, the Netherlands.
ISME Commun. 2025 Jul 16;5(1):ycaf119. doi: 10.1093/ismeco/ycaf119. eCollection 2025 Jan.
Fecal microbiota transplantation (FMT) is a promising treatment for the chronic immune-mediated disease ulcerative colitis (UC). However, the microbial dynamics underlying clinical remission remain poorly understood. To investigate these dynamics, we analysed data from 22 UC patients treated with four rounds of FMT donated by two healthy donors. Microbiota samples from patients were collected at nine timepoints before, during, and after treatment, covering a period of 14 weeks. Additionally, 27 donor samples were analysed. Species in the recipients' gut microbiota were categorised into ecological categories based on their origin and temporal dynamics: species already present in the recipient pre-FMT, species derived from the donor, or novel species, i.e. absent before FMT in both recipient and donor but detected during or after treatment. Overdispersed Poisson regression models were employed to model the number of species within each category over time. Furthermore, we investigated the change in relative abundance for recipient, colonising, and novel species. The results revealed that recipient species with higher relative abundances prior to FMT were more likely to persist following FMT. Notably, patients who achieved combined clinical and endoscopic remission at week 14 retained a higher number of recipient species compared to non-responders. In contrast, non-responders initially exhibited colonisation of more donor species than responders, but colonisation rate decreased over time in non-responders whereas colonisation rate remained stable in responders. These findings suggest that clinical remission following FMT is associated with controlled incorporation of donor species without replacement of resident species, which may reflect a resilient recipient gut community.
粪便微生物群移植(FMT)是治疗慢性免疫介导疾病溃疡性结肠炎(UC)的一种有前景的疗法。然而,临床缓解背后的微生物动态仍知之甚少。为了研究这些动态,我们分析了22例接受四轮FMT治疗的UC患者的数据,这些FMT由两名健康供体捐赠。在治疗前、治疗期间和治疗后的九个时间点收集患者的微生物群样本,涵盖14周的时间。此外,还分析了27份供体样本。根据受者肠道微生物群中物种的来源和时间动态,将其分类为生态类别:FMT前受者体内已存在的物种、来自供体的物种或新物种,即FMT前在受者和供体中均不存在但在治疗期间或治疗后检测到的物种。采用过度分散的泊松回归模型对每个类别中物种数量随时间的变化进行建模。此外,我们还研究了受者物种、定植物种和新物种相对丰度的变化。结果显示,FMT前相对丰度较高的受者物种在FMT后更有可能持续存在。值得注意的是,在第14周实现临床和内镜联合缓解的患者与无反应者相比,保留的受者物种数量更多。相比之下,无反应者最初表现出比反应者更多的供体物种定植,但无反应者的定植率随时间下降,而反应者的定植率保持稳定。这些发现表明,FMT后的临床缓解与供体物种的受控纳入有关,而不会取代常驻物种,这可能反映了受者肠道群落的弹性。